153 related articles for article (PubMed ID: 38338374)
1. Synthesis and Primary Activity Assay of Novel Benitrobenrazide and Benserazide Derivatives.
Juszczak K; Szczepankiewicz W; Walczak K
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338374
[TBL] [Abstract][Full Text] [Related]
2. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
3. Hexokinase 2 Inhibition and Biological Effects of BNBZ and Its Derivatives: The Influence of the Number and Arrangement of Hydroxyl Groups.
Juszczak K; Kubicka A; Kitel R; Dzido G; Łabieniec-Watała M; Zawadzki S; Marczak A; Walczak K; Matczak K; Tomczyk MD
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269760
[TBL] [Abstract][Full Text] [Related]
4. Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease.
Kim BK; Cho JH; Jeong P; Lee Y; Lim JJ; Park KR; Eom SH; Kim YC
FEBS Lett; 2015 Jul; 589(15):1795-801. PubMed ID: 26022398
[TBL] [Abstract][Full Text] [Related]
5. Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid.
Bender DA
Biochem Pharmacol; 1980 Mar; 29(5):707-12. PubMed ID: 20227944
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial Synthesis of Novel 3/5(3,5)-(Di)nitro/chloropaeonol Carbonyl Hydrazone Derivatives as Nematicidal Agents.
Chen G; Zhu L; Xia Y; Yang J; Zhang S; Li Y; Guo X; Sun D; He J; Tian Y; Liu S; Jiang J; Che Z
Comb Chem High Throughput Screen; 2022; 25(6):1031-1039. PubMed ID: 33761851
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues.
Lyles GA; Callingham BA
Biochem Pharmacol; 1982 Apr; 31(7):1417-24. PubMed ID: 7092930
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, Anti-Proliferative, Anti-microbial, Anti-Angiogenic Activity and
Ünver H; Berber B; Demirel R; Koparal AT
Anticancer Agents Med Chem; 2019; 19(13):1658-1669. PubMed ID: 30887930
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tryptophan hydroxylase by benserazide and other catechols.
Johansen PA; Wolf WA; Kuhn DM
Biochem Pharmacol; 1991 Feb; 41(4):625-8. PubMed ID: 1997008
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular structure and urease inhibitory activity of novel
Ahmad R; Khan M; Alam A; Elhenawy AA; Qadeer A; AlAsmari AF; Alharbi M; Alasmari F; Ahmad M
Saudi Pharm J; 2023 Aug; 31(8):101688. PubMed ID: 37457366
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, 'ADMET-SAR' Prediction, DPPH Assay, and Anti-Mycobacterium Study of 4-[(substituted benzyl) amino]benzo hydrazides and its Hydrazones as the Acyl-CoA Carboxylase, AccD5 Inhibitors.
Desale VJ; Mali SN; Thorat BR; Yamgar RS; Dharanguttikar SV; Dharanguttikar VR; Chtita S; Oliveira M; Cruz JN
Curr Comput Aided Drug Des; 2023; 19(4):300-312. PubMed ID: 36578253
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities.
Wang W; Wu Y; Yang K; Wu C; Tang R; Li H; Chen L
Eur J Med Chem; 2019 Jul; 173():282-293. PubMed ID: 31009914
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
Ho AK; Smith JA
Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
[TBL] [Abstract][Full Text] [Related]
14. Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes.
Kucukoglu K; Gul HI; Taslimi P; Gulcin I; Supuran CT
Bioorg Chem; 2019 May; 86():316-321. PubMed ID: 30743172
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
[TBL] [Abstract][Full Text] [Related]
16. Investigation into the Thermal Response and Pharmacological Activity of Substituted Schiff Bases on α-Amylase and α-Glucosidase.
Okoli BJ; Modise JS
Antioxidants (Basel); 2018 Aug; 7(9):. PubMed ID: 30154344
[TBL] [Abstract][Full Text] [Related]
17. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
Jonkers N; Sarre S; Ebinger G; Michotte Y
J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
[TBL] [Abstract][Full Text] [Related]
18. Effect of benserazide on the levels of pineal 5-hydroxytryptamine, melatonin synthesising enzymes and serum melatonin.
Ho AK; Smith JA
Biochem Pharmacol; 1982 Jul; 31(13):2251-5. PubMed ID: 6889864
[TBL] [Abstract][Full Text] [Related]
19. A new series of hydrazones as small-molecule aldose reductase inhibitors.
Altıntop MD; Demir Y; Türkeş C; Öztürk RB; Cantürk Z; Beydemir Ş; Özdemir A
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
[TBL] [Abstract][Full Text] [Related]
20. Renal response to amino acid infusion in rats: effect of dopamine receptor antagonists and benserazide.
Mühlbauer B; Hartenburg E; Osswald H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):244-9. PubMed ID: 8208302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
